Ocular biomarkers for anemia in diabetic kidney disease include disruption of the external limiting membrane and ellipsoid zone.

DRUGS may induce anemia by a variety of mechanisms, 1 including blood loss, hemolysis, bone-marrow suppression and megaloblastic arrest. Anticonvulsants 2 such as diphenylhydantoin, 3 the ...

A recent modeling study has identified risk factors predictive of good and bad outcomes in non-diabetic CKD, such as gender, race, and albuminuria.

Anemia is common in patients who have both heart failure and chronic kidney disease, and there is an association between anemia and progression of both diseases. The main causes of anemia are ...

Objectives To provide a comprehensive overview of interventions that support shared decision-making (SDM) for treatment modality decisions in advanced kidney disease (AKD). To provide summarised ...

Almost 36 million Americans have chronic kidney disease or CKD, and 9 out of 10 of those people don’t know they have it. Most people have a pair of kidneys, which are organs located below the ribs ...

usually in stage four or five CKD, who still have a hemoglobin less than 10, assuming you've excluded other diseases like myeloma or something to cause their anemia, these patients are good ...

In this study, both anemia and chronic kidney disease were highly prevalent among HF patients discharged from two university hospitals and independently associated with an increased risk of dying ...

Semaglutide is now approved for T2D patients with CKD, reducing cardiovascular and kidney disease risks. The FLOW phase 3b trial showed significant reductions in adverse kidney and cardiovascular ...

Chronic kidney disease (CKD) increases the risk of myocardial infarction and anemia. The optimal red blood cell transfusion threshold for patients with CKD and myocardial infarction remains unclear.